Peer Review reports
From: Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial
| Original Submission | ||
|---|---|---|
| 2 Sep 2020 | Submitted | Original manuscript |
| 12 Sep 2020 | Author responded | Author comments - Marzieh Nojomi |
| Resubmission - Version 2 | ||
| 12 Sep 2020 | Submitted | Manuscript version 2 |
| 5 Oct 2020 | Reviewed | Reviewer Report |
| 10 Oct 2020 | Reviewed | Reviewer Report |
| 27 Oct 2020 | Author responded | Author comments - Marzieh Nojomi |
| Resubmission - Version 3 | ||
| 27 Oct 2020 | Submitted | Manuscript version 3 |
| 4 Nov 2020 | Reviewed | Reviewer Report |
| 21 Nov 2020 | Reviewed | Reviewer Report |
| 25 Nov 2020 | Author responded | Author comments - Marzieh Nojomi |
| Resubmission - Version 4 | ||
| 25 Nov 2020 | Submitted | Manuscript version 4 |
| 3 Dec 2020 | Author responded | Author comments - Marzieh Nojomi |
| Resubmission - Version 5 | ||
| 3 Dec 2020 | Submitted | Manuscript version 5 |
| Publishing | ||
| 8 Dec 2020 | Editorially accepted | |
| 14 Dec 2020 | Article published | 10.1186/s12879-020-05698-w |
You can find further information about peer review here.